Net Change in Cash
Vertex Pharmaceuticals Net Change in Cash increased by 509.4% to $140.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 120.7%, from -$675.90M to $140.00M. Over 4 years (FY 2021 to FY 2025), Net Change in Cash shows a downward trend with a -10.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
cf_net_change_in_cashHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$241.84M | $209.15M | $519.83M | $803.90M | $1.10B | $472.90M | $1.34B | -$1.22B | $857.80M | $963.20M | -$744.30M | -$1.20B | -$4.58B | $657.10M | -$675.90M | $113.20M | $296.60M | -$34.20M | $140.00M |
| QoQ Change | — | +186.5% | +148.6% | +54.6% | +36.8% | -57.0% | +182.3% | -191.1% | +170.5% | +12.3% | -177.3% | -61.6% | -280.6% | +114.4% | -202.9% | +116.7% | +162.0% | -111.5% | +509.4% |
| YoY Change | — | — | — | — | +554.9% | +126.1% | +156.8% | -251.3% | -22.0% | +103.7% | -155.8% | +1.1% | -633.7% | -31.8% | +9.2% | +109.4% | +106.5% | -105.2% | +120.7% |
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's net change in cash?
- Vertex Pharmaceuticals (VRTX) reported net change in cash of $140.00M in Q4 2025.
- How has Vertex Pharmaceuticals's net change in cash changed year-over-year?
- Vertex Pharmaceuticals's net change in cash increased by 120.7% year-over-year, from -$675.90M to $140.00M.
- What is the long-term trend for Vertex Pharmaceuticals's net change in cash?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's net change in cash has grown at a -10.7% compound annual growth rate (CAGR), from $811.20M to $515.60M.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.